-
Study aim
-
Comparative evaluation of the efficacy of Entonox Gas analegesia alone and in combination with magnesium sulfate in painless delivery in multipar mild preeclampsic patient 2019-2020
-
Design
-
This evaluation is a phase 3 clinical trial with a control group with parallel, not blinded and not randomized groups, accordingly, 35 people will be evaluated in each group.
-
Settings and conduct
-
This study was carried out as a clinical trial at the Ali ibn Abi Talib Hospital, also the study will not be blinded.
-
Participants/Inclusion and exclusion criteria
-
Pregnant women with preeclampsia, gestational age of 38 to 42 weeks, single fetus with cephalic presentation, in early active phase of labor, having normal fetal heart pattern, 60 to 80 kg weight, having no heart problems and other internal diseases, aged 20 to 40 years will be considered as study groups. Samples with onsciousness disorder and poisoning, maxillofacial surgery in the last month, internal ear obstruction, fetal distress, unstable hemodynamic status, airway dysfunction, maternal gastric emptying and neuropsychiatric disorder will excluded from study.
-
Intervention groups
-
In intervention group, mothers with start of pain, gas inhalation Entonox will start and soon overcome the pain, gas inhalation by the mother stops, mothers receive gas to second stage of labor. Also normal saline is given in a similar dose with a bolus dose of magnesium sulfate and then 20 cc infusions.
-
Main outcome variables
-
Pain severity